Why should I care about patient engagement/the patient perspective – why should it be important to me?
We put the patient at the centre of everything we do because behind every treatment is a person whose life could be changed. By understanding and always thinking about the patient experience and the patient journey, you create brand narratives that are more authentic, emotional and credible – the kind that actually move people.
Why should I read the GPPG – what’s in it for me?
You get out, what you put in. Never has this been truer than for patient insight, specifically Patient Journey Mapping - the subject tackled by this year's GPPG. Marketing teams and launch leads should be challenging the depth and breadth of the patient experience that drives their decision-making and asking if they could and should do more to partner in this area. This year's GPPG is a great starting point for that debate.
Why should I care about patient engagement/the patient perspective – why should it be important to me?
Involving patients helps ensure that educational content is grounded in lived experience, not just clinical data. When physicians hear the patient voice, it connects them with the material and becomes more deeply embedded in their thoughts and actions. Educating HCPS on how to engage with patients improves communication and ultimately treatment outcomes.
Why should I read the GPPG – what’s in it for me?
This edition of the Good Patient Partnership Guide (GPPG), with its focus on best practice in patient journey mapping, is a must read for medical affairs professionals. Understanding the patient journey enhances scientific credibility and strengthens relationships with healthcare professionals. This edition of GPPG gives people working in medical affairs an invaluable opportunity to learn, reflect and possibly even improve their own current practice.
Why should I care about patient engagement/the patient perspective – why should it be important to me?
Great work is being done by the pharmaceutical industry, patient opinion leaders, individuals with lived experience and the groups representing them. But is it enough – is it truly having the impact it set out to achieve? Could the harnessing of lived experience from the outset of all projects elevate efforts and outputs to a new level? Could it add value to ensure a meaningful difference is made for patients, and for a company's bottom line which, after all, needs to be healthy to enable ongoing investment into research and development and continued drug discovery to improve patient outcomes? Yes, so let’s engage well with the patient community.
Why should I read the GPPG – what’s in it for me?
You will uncover insights from patient groups, patient advocates and pharmaceutical and medical device expert professionals along with inspirational ideas and case studies to enhance your approach to journey mapping to ensure whatever valuable work you are doing goes from ‘great’ to ‘excellent’, is rooted in lived experience, and goes beyond the clinical pathway to include emotional, practical and social realities.
Why should I care about patient engagement/the patient perspective – why should it be important to me?
The key to success in healthcare communications is knowing your audience; knowing what they want communicated to them and how they want to be communicated with. The GPPG provides all-important insight into the perspective of the patient community, and those partnering with it, enabling you to create communication assets that will really cut through the noise.
Why should I read the GPPG – what’s in it for me?
You should read GPPG because it is grounded in insights from the patient community on how to improve patient journey mapping through a partnership approach. This will enable healthcare organisations to create communication messages that reflect the lived patient experience including diverse patient communities and under-represented voices. This results in richer storytelling for disease awareness, thought leadership and stakeholder engagement.
Why should I care about patient engagement/the patient perspective – why should it be important to me?
We are often asked how we are going to simplify scientific content in our training and education materials, whether it is for HCPs, sales reps or patients. It supports everyone to bring a patient-first focus to training materials. By providing content that is easier to understand, HCPs are prompted to use simpler language and visual approaches in their discussions with patients.
Why should I read the GPPG – what’s in it for me?
From an L&D perspective, partnership‑led patient journey mapping is not just a methodology but a capability that must be intentionally built across teams. Comprehensive understanding of lived experience enables us to embed this into training to ensure that learning becomes the bridge between insight and real‑world impact.
Why should I care about patient journey mapping – why should it be important to me?
Patient journey mapping matters in Market Access because it turns “unmet need” from a generic claim into a clear, evidence-led explanation of where patients get delayed, excluded, or drop off (diagnosis, referral, testing, prior authorisation, affordability, adherence/persistence), and what that costs the system in avoidable outcomes and resource use. This enables you to build a more payer-relevant value story, target HEOR/RWE to the touchpoints that actually drive utilisation and inequity (not just the guideline pathway), and align cross-functional teams around the real barriers to uptake and outcomes rather than assumptions.
Why should I read the GPPG – what’s in it for me?
You should read the GPPG because it gives you a practical “quality standard” for how to do journey mapping with patient communities in a way that is credible and usable. It frames this as guidance for life sciences teams including Market Access, offering principles and practical recommendations to make engagement more repeatable, equitable, and actionable (which ultimately makes your access narrative and supporting insight more defensible).
